Pramipexole is a dopamine agonist with high selectivity and specificity for dopamine receptors. Pramipexole facilitates parkinsonian movement disorders by stimulation of the striatum (striatum) of dopamine receptors.
Indications of “Pramipexole ІС”: treating the symptoms of idiopathic Parkinson’s disease in adults as monotherapy (without levodopa) or in combination with levodopa, symptomatic treatment of idiopathic restless legs syndrome moderate to severe adult.
Trade name: Pramipexole ІC
Dosage form: tablets of 0.25 mg and 1 mg
Pharmacotherapeutic group: Dopaminergic agents. Dopamine agonists.
ATC code N04B C05.
Registration number: № UA / 15526/01/01, № UA / 15526/01/02
Registration date / valid until: 10.11.2016 / 10.11.2021
Packaging: tablets № 30 (10 × 3) in the blister pack
Shelf life: 2 years
Legal category: prescription only medicine
Search